Vitamin D receptor polymorphism and colorectal cancer-specific and all-cause mortality

• Verfasst von: Perna, Laura [VerfasserIn]
• Verfasst von: Hoffmeister, Michael [VerfasserIn]
• Verfasst von: Schöttker, Ben [VerfasserIn]
• Verfasst von: Arndt, Volker [VerfasserIn]
• Verfasst von: Haug, Ulrike [VerfasserIn]
• Verfasst von: Holleczek, Bernd [VerfasserIn]
• Verfasst von: Burwinkel, Barbara [VerfasserIn]
• Verfasst von: Ordóñez Mena, José M. [VerfasserIn]
• Verfasst von: Brenner, Hermann [VerfasserIn]
• Titel: Vitamin D receptor polymorphism and colorectal cancer-specific and all-cause mortality
• Verf.angabe: Laura Perna, Michael Hoffmeister, Ben Schöttker, Volker Arndt, Ulrike Haug, Bernd Holleczek, Barbara Burwinkel, José M. Ordóñez-Mena, Hermann Brenner
• E-Jahr: 2013
• Jahr: 27 September 2013
• Umfang: 3 S.
• Fussnoten: Gesehen am 10.01.2022
• Titel Quelle: Enthalten in: Cancer epidemiology
• Ort Quelle: Amsterdam [u.a.] : Elsevier, 2009
• Jahr Quelle: 2013
• Band/Heft Quelle: 37(2013), 6, Seite 905-907
• ISSN Quelle: 1877-783X
• DOI: doi:10.1016/j.canep.2013.09.007
• Datenträger: Online-Ressource
• Sprache: eng
• Bibliogr. Hinweis: Erscheint auch als : Druck-Ausgabe: Perna, Laura: Vitamin D receptor polymorphism and colorectal cancer-specific and all-cause mortality. - 2013
• Sach-SW: Cancer prognosis
• Sach-SW: Colorectal cancer
• Sach-SW: VDR polymorphism
• Sach-SW: Vitamin D
• K10plus-PPN: 178532506X

Abstract

Background - The vitamin D receptor (VDR) gene is present in colorectal cancer (CRC) cells and its genetic variants have been associated with an increased risk of CRC. The association with colorectal cancer prognosis remains widely unexplored. - Methods - 1397 colorectal cancer patients participating in two cancer cohorts (ESTHER II and VERDI) and in a population-based case-control study (DACHS) were followed for 5 years. Unadjusted and adjusted hazard ratios for all-cause mortality (469 events) and CRC-specific mortality (336 events) were estimated for VDR variants rs731236 (TaqI), rs2228570 (FokI), rs11568820 (Cdx2), and rs1989969 (VDR-5132). - Results - No association was found between VDR polymorphism and CRC specific and all-cause mortality. Adjusted hazard ratios ranged from 0.79 (95% CI 0.57-1.12) to 1.14 (95% CI 0.89-1.46) for CRC-specific mortality and from 0.89 (95% CI 0.67-1.18) to 1.22 (95% CI 0.99-1.50) for all-cause mortality. All 95% confidence intervals included the null value. - Conclusions - Our findings do not support the hypothesis that the common VDR gene variants investigated in this study are of clinical relevance with respect to CRC prognosis.